54.50
price down icon1.71%   -0.95
pre-market  시장 영업 전:  54.81   0.31   +0.57%
loading
전일 마감가:
$55.45
열려 있는:
$54.37
하루 거래량:
2.46M
Relative Volume:
1.03
시가총액:
$137.99B
수익:
$48.03B
순이익/손실:
$6.06B
주가수익비율:
21.81
EPS:
2.4983
순현금흐름:
$9.91B
1주 성능:
-7.00%
1개월 성능:
-0.82%
6개월 성능:
-4.39%
1년 성능:
+9.55%
1일 변동 폭
Value
$53.98
$54.84
1주일 범위
Value
$53.98
$58.16
52주 변동 폭
Value
$45.22
$60.12

사노피 ADR Stock (SNY) Company Profile

Name
명칭
Sanofi Adr
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
@sanofi
Name
다음 수익 날짜
2024-10-25
Name
최신 SEC 제출 서류
Name
SNY's Discussions on Twitter

SNY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
SNY
Sanofi Adr
54.50 137.99B 48.03B 6.06B 9.91B 2.4983
Drug Manufacturers - General icon
LLY
Lilly Eli Co
826.76 742.57B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
201.30 356.10B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
161.72 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
71.73 334.39B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
MRK
Merck Co Inc
88.11 235.20B 64.17B 17.12B 18.10B 6.73

사노피 ADR Stock (SNY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-21 개시 Goldman Neutral
2025-01-30 업그레이드 Deutsche Bank Sell → Hold
2024-07-26 재확인 Argus Buy
2024-01-23 개시 Morgan Stanley Equal-Weight
2024-01-16 재개 UBS Buy
2023-12-05 다운그레이드 JP Morgan Overweight → Neutral
2023-10-30 다운그레이드 Stifel Buy → Hold
2023-09-06 업그레이드 Berenberg Hold → Buy
2023-07-14 개시 HSBC Securities Buy
2023-04-28 다운그레이드 Deutsche Bank Hold → Sell
2023-03-27 업그레이드 Barclays Equal Weight → Overweight
2022-12-13 재개 Morgan Stanley Overweight
2022-08-12 업그레이드 Deutsche Bank Sell → Hold
2022-08-09 다운그레이드 UBS Buy → Neutral
2022-05-23 개시 SVB Leerink Outperform
2021-09-27 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-01-15 개시 Deutsche Bank Sell
2020-09-29 개시 Berenberg Hold
2020-03-17 업그레이드 Barclays Underweight → Equal Weight
2020-03-11 업그레이드 Goldman Neutral → Buy
2020-02-11 개시 SVB Leerink Mkt Perform
2020-01-06 업그레이드 JP Morgan Neutral → Overweight
2019-09-23 업그레이드 Guggenheim Neutral → Buy
2019-09-20 업그레이드 Morgan Stanley Equal-Weight → Overweight
2019-09-03 개시 Bernstein Outperform
2019-08-14 업그레이드 UBS Neutral → Buy
2018-12-11 업그레이드 Jefferies Hold → Buy
2018-11-01 업그레이드 Barclays Underweight → Equal Weight
2018-10-09 개시 Guggenheim Neutral
2018-09-10 업그레이드 BofA/Merrill Neutral → Buy
2018-08-10 업그레이드 Citigroup Neutral → Buy
2018-03-23 업그레이드 Liberum Hold → Buy
2018-01-23 다운그레이드 Barclays Equal Weight → Underweight
2017-12-06 다운그레이드 BofA/Merrill Buy → Neutral
2017-12-01 다운그레이드 Morgan Stanley Overweight → Underweight
2017-11-15 업그레이드 Barclays Underweight → Equal Weight
2017-08-30 업그레이드 HSBC Securities Reduce → Hold
모두보기

사노피 ADR 주식(SNY)의 최신 뉴스

pulisher
Mar 26, 2025

[Latest] Global Fabry Disease Treatment Market Size/Share Worth USD 7.02 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.

Mar 26, 2025
pulisher
Mar 26, 2025

4 healthcare stocks attractive on valuation and ESG risk - Morningstar.com.au

Mar 26, 2025
pulisher
Mar 18, 2025

SNY Quantitative Stock Analysis - Nasdaq

Mar 18, 2025
pulisher
Mar 17, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 12, 2025

Know Labs Inc (KNW) Stock: A Closer Look at the Market Potential - The News Heater

Mar 12, 2025
pulisher
Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025
pulisher
Feb 27, 2025

Piper Sandler Shows Market Leadership With Jump To 83 RS Rating - Inkl

Feb 27, 2025
pulisher
Feb 26, 2025

Sanofi ADR Shows Market Leadership With Jump To 82 RS Rating - Investor's Business Daily

Feb 26, 2025
pulisher
Feb 25, 2025

Gold Field ADR Sees Its Composite Rating Rise To 99 - Inkl

Feb 25, 2025
pulisher
Feb 24, 2025

ZEEKR Intelligent ADR Shows Rising Price Performance With Jump To 80 RS Rating - Inkl

Feb 24, 2025
pulisher
Feb 17, 2025

Validea Detailed Fundamental AnalysisSNY - Nasdaq

Feb 17, 2025
pulisher
Feb 14, 2025

Harrow Earns Relative Strength Rating Upgrade - Inkl

Feb 14, 2025
pulisher
Feb 13, 2025

Sanofi ADR Earns RS Rating Upgrade - Investor's Business Daily

Feb 13, 2025
pulisher
Feb 11, 2025

Newmont Earns RS Rating Upgrade - Inkl

Feb 11, 2025
pulisher
Feb 07, 2025

What was Skechers U S A, Inc (SKX)’s performance in the last session? - US Post News

Feb 07, 2025
pulisher
Feb 07, 2025

Sanofi ADR (SNY) requires closer examination - US Post News

Feb 07, 2025
pulisher
Feb 05, 2025

Sanofi ADR (SNY): A Technical Analysis - The News Heater

Feb 05, 2025
pulisher
Feb 05, 2025

GNPX’s Market Whiplash: -38.94% YTD Decline, -42.28% Plunge in 30 Days - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Applied Materials Inc’s Banking’s 100-Day Moving Average at 182.60: Will the Stock Break Through? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

ESPR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 04, 2025

Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend - Investor's Business Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025
pulisher
Jan 30, 2025

Sanofi Reports Strong Q4 Sales Growth, Plans €5 Billion Buyback in 2025 - GuruFocus.com

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR earnings beat by $0.53, revenue fell short of estimates - Investing.com South Africa

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR (SNY) Recovers 15.33% From Low: Are We There Yet? - Stocks Register

Jan 30, 2025
pulisher
Jan 29, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Jan 29, 2025
pulisher
Jan 25, 2025

AECOM (NYSE: ACM) Is A Blank Check For Growth - Stocks Register

Jan 25, 2025
pulisher
Jan 25, 2025

Shares Of Pennymac Mortgage Investment Trust (NYSE: PMT): Are They Overvalued Compared To Others? - Stocks Register

Jan 25, 2025

사노피 ADR (SNY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$109.27
price up icon 1.28%
drug_manufacturers_general PFE
$25.21
price down icon 1.33%
$305.71
price down icon 0.37%
drug_manufacturers_general NVS
$110.14
price down icon 0.22%
drug_manufacturers_general MRK
$88.11
price up icon 0.27%
자본화:     |  볼륨(24시간):